COMPOSITIONS OF AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY

• 收藏
• 分享

专利权人:

发明人:

申请号：

HK14110093.9

公开号：

HK1196560A

申请日:

2014.10.09

申请国别(地区):

HK

年份:

2014

代理人:

摘要：

The present invention relates to specific doses of and dosing regimens for using a 1,2,4-oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[l,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/